NCT07901868
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07901868
Title Elranatamab With Mezigdomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma (GEM-MeziDEL)
Acronym GEM-MeziDEL
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors PETHEMA Foundation
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Complejo Hospitalario de Albacete Albacete 02006 Spain Details
Hospital General Universitario Dr. Balmis Alicante Spain Details
Hospital Universitari Germans Trias i Pujol (ICO Badalona) Badalona Spain Details
H. Moises Broggi Barcelona Spain Details
Hospital Clínic de Barcelona Barcelona Spain Details
Hospital de Cabueñes Gijón Spain Details
H. Un. Virgen de las Nieves Granada Spain Details
C. H. U. de Gran Canaria Dr. Negrín Las Palmas de Gran Canaria Spain Details
Complejo Hospitalario Lucus Augusti Lugo Spain Details
Hospital Doce de Octubre Madrid 28041 Spain Details
C. H. Gregorio Marañón Madrid Spain Details
Complejo Hospital Costa Del Sol (Ivcs) Málaga Spain Details
H. Un. Virgen de la Arrixaca Murcia Spain Details
Hospital Central de Asturias Oviedo Spain Details
Hospital Son Llatzer Palma de Mallorca Spain Details
Clínica Universidad de Navarra (CUN) Pamplona Spain Details
Hospital Clínico Universitario Salamanca Salamanca 37007 Spain Details
H. Universitario Marqués de Valdecilla Santander Spain Details
Hospital Universitari i Politecnic la Fe Valencia Spain Details
H. U. Txagorritxu Vitoria-Gasteiz Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field